sales@targetmol.com (US) / info@targetmol.com    Tel: (781) 999-4286 / (781) 999-5354
Home > PLK
PLK
Cat.No. Product Name Information Area
T6282 GSK461364 GSK461364(Ki=2.2 nM) inhibits purified Plk1 .The specificity of GSK461364 for Plk1 is... Cancer
T6247 NMS-P937 (NMS1286937) NMS-P937 (NMS1286937), an oral, specific Polo-like Kinase 1 (PLK1) inhibitor, is wit... Cancer
T6173 BI 2536 BI2536 is an effective Plk1 inhibitor (IC50: 0.83 nM). It has 4- and 11-fold greater ... Cancer
T6070 Rigosertib (ON-01910) Rigosertib, a non-ATP-competitive inhibitor of PLK1(IC50=9 nM), exhibits 30-fold high... Cancer
T6019 Volasertib (BI 6727) Volasertib is a dihydropteridinone Polo-like kinase 1 (Plk1) inhibitor(IC50=0.87 nM) ... Cancer
T2704 MLN0905 MLN0905 is an effective PLK1 inhibitor(IC50=2 nM). Cancer
T2634 Ro3280 Ro3280 is an effective, specific inhibitor of PLK1(IC50=3, Kd=0.09 nM).
T2438 HMN-214 HMN-214(IVX214) is a potent PLK1 inhibitor with an average IC50 of 0.12 μM. Cancer
T2271 SBE13 Hydrochloride SBE13 hydrochloride is an effective and specific PLK1 inhibitor (IC50: 0.2 nM); no in... Other
T0973 Pyridoxine Pyridoxine is the 4-methanol form of vitamin B6 and is converted to pyridoxal 5-phosp... Nervous system
1